Community‐acquired pneumonia (CAP) is a common cause of morbidity and mortality in
adults worldwide, but its epidemiology varies markedly by region. Whilst in high‐income …

Pneumocystis pneumonia (PcP) is a serious fungal infection among immunocompromised
patients. In developed countries, the epidemiology and clinical spectrum of PcP have been …

Background Few comprehensive data exist on disease incidence for specific etiologies of
acute respiratory illness (ARI) in older children and adults in Africa. Methodology/Principal …

Rationale: In the context of rapid antiretroviral therapy rollout and an increasing burden of
noncommunicable diseases, there are few contemporary data describing the etiology and …

The respiratory fluoroquinolones moxifloxacin, gemifloxacin, and high-dose levofloxacin are
recommended in guidelines for effective empirical antimicrobial therapy of community …

Abstract Background: The epidemiology of Pneumocystis jirovecii, known to colonize the
respiratory tract and cause a life-threatening HIV-associated pneumonia (PCP), is poorly …

Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome
coronavirus 2 is a global pandemic that has resulted in over 1.5 million confirmed cases and …

Several factors contribute to the high mortality attributed to severe infections in resource-
limited settings. While improvements in survival and processes of care have been made in …

Community-acquired pneumonia (CAP) in sub-Saharan Africa is a common cause of adult
hospitalization and is associated with significant mortality. Human immunodeficiency virus …

Pneumocystis jirovecii pneumonia (PCP) is an important opportunistic infection in patients
infected with HIV, but its burden is incompletely characterized in those areas of sub-Saharan …